Search research articles
Contact Us
Filters
Showing results (281-290 of 438) with videos related to
Page
of 44
Sort By:
BMC Infectious Diseases
|
February 1, 2015
Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013
Fiodar Lebedzeu, Daniel Golparian, Leonid Titov, et al.
The Journal of Antimicrobial Chemotherapy
|
March 2, 2019
Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16
Ricardo A Gianecini, Daniel Golparian, Sandra Zittermann, et al.
Journal of Clinical Microbiology
|
June 29, 2018
Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens
Valentina Donà, Joost H Smid, Sara Kasraian, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
August 25, 2015
Evaluation of the new AmpliSens multiplex real-time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis
Tatiana Rumyantseva, Daniel Golparian, Christian S Nilsson, et al.
Journal of Clinical Microbiology
|
April 3, 2015
Successful Combination of Nucleic Acid Amplification Test Diagnostics and Targeted Deferred Neisseria gonorrhoeae Culture
Carolien M Wind, Henry J C de Vries, Maarten F Schim van der Loeff, et al.
Sexually Transmitted Infections
|
June 16, 2022
Performance of the first commercial dual resistance assay, AmpliSens <i>Mycoplasma genitalium</i>-ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of <i>M. genitalium</i> resistance mutations in St. Petersburg, Russia
Elena Shipitsyna, Tatiana Khusnutdinova, Olga Budilovskaya, et al.
The Lancet Regional Health. Western Pacific
|
October 27, 2025
The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024
Pham Thi Lan, Thuy Thi Phan Nguyen, Vu Tuan Anh, et al.
Microorganisms
|
August 3, 2019
The Finnish New Variant of <i>Chlamydia trachomatis</i> with a Single Nucleotide Polymorphism in the 23S rRNA Target Escapes Detection by the Aptima Combo 2 Test
Kati Hokynar, Kaisu Rantakokko-Jalava, Antti Hakanen, et al.
The Lancet. Infectious Diseases
|
June 23, 2020
Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction
Arlene C Seña, Laura Bachmann, Christine Johnston, et al.
BMC Genomics
|
February 5, 2020
Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928-2013): antimicrobial use/misuse selects for resistance and drives evolution
Daniel Golparian, Simon R Harris, Leonor Sánchez-Busó, et al.
Page
of 44
Search research articles
Search
Showing results (281-290 of 438) with videos related to
Sort By:
Page
of 44
BMC Infectious Diseases
|
February 1, 2015
Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013
Fiodar Lebedzeu, Daniel Golparian, Leonid Titov, et al.
The Journal of Antimicrobial Chemotherapy
|
March 2, 2019
Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16
Ricardo A Gianecini, Daniel Golparian, Sandra Zittermann, et al.
Journal of Clinical Microbiology
|
June 29, 2018
Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens
Valentina Donà, Joost H Smid, Sara Kasraian, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
August 25, 2015
Evaluation of the new AmpliSens multiplex real-time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis
Tatiana Rumyantseva, Daniel Golparian, Christian S Nilsson, et al.
Journal of Clinical Microbiology
|
April 3, 2015
Successful Combination of Nucleic Acid Amplification Test Diagnostics and Targeted Deferred Neisseria gonorrhoeae Culture
Carolien M Wind, Henry J C de Vries, Maarten F Schim van der Loeff, et al.
Sexually Transmitted Infections
|
June 16, 2022
Performance of the first commercial dual resistance assay, AmpliSens <i>Mycoplasma genitalium</i>-ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of <i>M. genitalium</i> resistance mutations in St. Petersburg, Russia
Elena Shipitsyna, Tatiana Khusnutdinova, Olga Budilovskaya, et al.
The Lancet Regional Health. Western Pacific
|
October 27, 2025
The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024
Pham Thi Lan, Thuy Thi Phan Nguyen, Vu Tuan Anh, et al.
Microorganisms
|
August 3, 2019
The Finnish New Variant of <i>Chlamydia trachomatis</i> with a Single Nucleotide Polymorphism in the 23S rRNA Target Escapes Detection by the Aptima Combo 2 Test
Kati Hokynar, Kaisu Rantakokko-Jalava, Antti Hakanen, et al.
The Lancet. Infectious Diseases
|
June 23, 2020
Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction
Arlene C Seña, Laura Bachmann, Christine Johnston, et al.
BMC Genomics
|
February 5, 2020
Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928-2013): antimicrobial use/misuse selects for resistance and drives evolution
Daniel Golparian, Simon R Harris, Leonor Sánchez-Busó, et al.
Page
of 44